Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Targeted treatment offers Alzheimer's hope

  • Comment

Targeting of the protein neutral sphingomyelinase (N-SMase) could potentially lead to a new way to prevent the progression of Alzheimer’s disease, according to American research.

When activated the protein can caused reactions in cells leading to neuronal death and memory loss.

The study states that if activation can be prevented memory loss and progression of Alzheimer’s in patients may be able to be stopped.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs